BioProcess Insider - News BioProcess International

Novavax says COVID $1.6bn funding helps secure US-based supply chain

The ‘Operation Warp Speed’ $1.6 billion funding boost will help support the large-scale manufacture of COVID-19 vaccine candidate NVX‑CoV2373, says Novavax. Novavax has become the beneficiary of the largest funding by Operation Warp Speed – the US government’s response to the expedite v ...

Rentschler and Vetter team to take on rising drug cost and complexity
CDMOs Rentschler Biopharma and Vetter say demand for lower cost, more streamlined manufacturing services prompted partnership. The Germany-bas ...
The evolving demands of the temperature-controlled supply chain for cell and gene therapy
As drugs have become more complex, so too has the supply chain, which must innovate to accommodate the necessary, specialized conditions for the ...
Sarepta: ‘We have a voracious appetite for gene therapy manufacturing capacity’
Inhouse capabilities coupled with capacity at CDMOs including Thermo Fisher and Catalent have allowed Sarepta Therapeutics to rapidly advance its ...
US FDA says platforms can speed COVID-19 jab development
COVID-19 focused drug and vaccine firms need to keep a close eye on the US FDA according to lawyers who predict manufacturing and trial rules wil ...

Covering the whole development process for the global biotechnology industry

More From BioProcess Insider

Recent Tweets

Recent Tweets

Trending